Daphnetin

CAS No. 486-35-1

Daphnetin ( 7,8-Dihydroxycoumarin; NSC 633563 )

Catalog No. M14627 CAS No. 486-35-1

Daphnetin, a natural coumarin derivative, is a protein kinase inhibitor, inhibits EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively, also known to exhibit anti-inflammatory and anti-oxidant activities.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 39 In Stock
25MG 78 In Stock
50MG 152 In Stock
100MG 230 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Daphnetin
  • Note
    Research use only, not for human use.
  • Brief Description
    Daphnetin, a natural coumarin derivative, is a protein kinase inhibitor, inhibits EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively, also known to exhibit anti-inflammatory and anti-oxidant activities.
  • Description
    Daphnetin, a natural coumarin derivative, is a protein kinase inhibitor, inhibits EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively, also known to exhibit anti-inflammatory and anti-oxidant activities.
  • Synonyms
    7,8-Dihydroxycoumarin; NSC 633563
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR; PKA; PKC
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    486-35-1
  • Formula Weight
    178.14
  • Molecular Formula
    C9H6O4
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 35 mg/mL (196.47 mM)
  • SMILES
    O=C1C=CC2=CC=C(O)C(O)=C2O1
  • Chemical Name
    7,8-dihydroxy-2H-1-benzopyran-2-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang EB, et al. Biochem Biophys Res Commun, 1999, 260(3), 682-685.
molnova catalog
related products
  • Olmutinib

    Olmutinib (HM61713, BI-1482694) is a pontent and T790M-specific third-generation EGFR inhibitor for treatment of NSCLC.

  • Epimedin B

    Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.

  • AZD-9291 dimesylate

    A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively.